Biopharmx Corp (NYSEAMERICAN:BPMX) Director Anja B. Krammer sold 500,000 shares of the business’s stock in a transaction dated Friday, October 12th. The stock was sold at an average price of $0.19, for a total transaction of $95,000.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.
Biopharmx stock traded up $0.01 during trading hours on Friday, reaching $0.18. The stock had a trading volume of 2,382,600 shares, compared to its average volume of 7,818,001. Biopharmx Corp has a 52 week low of $0.10 and a 52 week high of $0.38.
Biopharmx (NYSEAMERICAN:BPMX) last announced its earnings results on Thursday, August 30th. The biotechnology company reported ($0.02) EPS for the quarter, hitting the Zacks’ consensus estimate of ($0.02). The firm had revenue of $0.02 million during the quarter, compared to the consensus estimate of $0.02 million.
Biopharmx Company Profile
BioPharmX Corporation, a specialty pharmaceutical company, develops and commercializes novel prescription and over-the-counter (OTC) products that address dermatology and women's health markets. The company offers VI2OLET, an OTC molecular iodine dietary supplement that addresses cyclic breast discomfort, as well as alleviates the symptoms of fibrocystic breast condition (FBC).
Further Reading: Investing in Dividend Stocks
Receive News & Ratings for Biopharmx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biopharmx and related companies with MarketBeat.com's FREE daily email newsletter.